Inflammatory Bowel Disease: A Potential Result from the Collusion between Gut Microbiota and Mucosal Immune System

Host health depends on the intestinal homeostasis between the innate/adaptive immune system and the microbiome. Numerous studies suggest that gut microbiota are constantly monitored by the host mucosal immune system, and any slight disturbance in the microbial communities may contribute to intestinal immune disruption and increased susceptibility to inflammatory bowel disease (IBD), a chronic relapsing inflammatory condition of the gastrointestinal tract. Therefore, maintaining intestinal immune homeostasis between microbiota composition and the mucosal immune system is an effective approach to prevent and control IBD. The overall theme of this review is to summarize the research concerning the pathogenesis of IBD, with particular focus on the factors of gut microbiota-mucosal immune interactions in IBD. This is a comprehensive and in-depth report of the crosstalk between gut microbiota and the mucosal immune system in IBD pathogenesis, which may provide insight into the further evaluation of the therapeutic strategies for IBD.

[1]  D. Fass,et al.  Intestinal Gel-Forming Mucins Polymerize by Disulfide-Mediated Dimerization of D3 Domains , 2019, Journal of molecular biology.

[2]  Louis J. Cohen,et al.  Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases. , 2019, Gastroenterology.

[3]  G. Docena,et al.  Contribution of Non-immune Cells to Activation and Modulation of the Intestinal Inflammation , 2019, Front. Immunol..

[4]  P. Pandiyan,et al.  Microbiome Dependent Regulation of Tregs and Th17 Cells in Mucosa , 2019, Front. Immunol..

[5]  W. Shi,et al.  c-Maf-dependent Treg cell control of intestinal TH17 cells and IgA establishes host–microbiota homeostasis , 2019, Nature Immunology.

[6]  D. Gevers,et al.  Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and ROR&ggr;t+ Regulatory T Cells and Exacerbate Colitis in Mice , 2019, Immunity.

[7]  Katherine R. Balka,et al.  Understanding early TLR signaling through the Myddosome , 2018, Journal of leukocyte biology.

[8]  G. Boeckxstaens,et al.  Intestinal macrophages and their interaction with the enteric nervous system in health and inflammatory bowel disease , 2018, Acta physiologica.

[9]  E. Chang,et al.  The intestinal microbiota in the pathogenesis of inflammatory bowel diseases: new insights into complex disease. , 2018, Clinical science.

[10]  Xiaotian Chen,et al.  Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1. , 2018, Inflammatory bowel diseases.

[11]  Takashi Sato,et al.  Immune synergistic oligodeoxynucleotide from Lactobacillus rhamnosus GG enhances the immune response upon co-stimulation by bacterial and fungal cell wall components. , 2018, Animal science journal = Nihon chikusan Gakkaiho.

[12]  S. Ng,et al.  Urbanization and the gut microbiota in health and inflammatory bowel disease , 2018, Nature Reviews Gastroenterology & Hepatology.

[13]  E. Martens,et al.  Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier , 2018, Nature Reviews Microbiology.

[14]  Jing Li,et al.  Helicobacter pylori Colonization Protects Against Chronic Experimental Colitis by Regulating Th17/Treg Balance. , 2018, Inflammatory bowel diseases.

[15]  Zhengtao Wang,et al.  Anti-Inflammatory Effects of Fargesin on Chemically Induced Inflammatory Bowel Disease in Mice , 2018, Molecules.

[16]  A. Rudensky,et al.  Extrathymically Generated Regulatory T Cells Establish a Niche for Intestinal Border‐Dwelling Bacteria and Affect Physiologic Metabolite Balance , 2018, Immunity.

[17]  J. Gisbert,et al.  Human Intestinal Dendritic Cells in Inflammatory Bowel Diseases. , 2018, Molecular nutrition & food research.

[18]  Zhenhong Wei,et al.  The Immunoregulation of Th17 in Host against Intracellular Bacterial Infection , 2018, Mediators of inflammation.

[19]  L. Birnbaumer,et al.  Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response , 2018, Proceedings of the National Academy of Sciences.

[20]  M. Kleinewietfeld,et al.  Interrelation of Diet, Gut Microbiome, and Autoantibody Production , 2018, Front. Immunol..

[21]  J. Kagan,et al.  How Inflammasomes Inform Adaptive Immunity. , 2018, Journal of molecular biology.

[22]  D. Haller,et al.  Bacterial Signaling at the Intestinal Epithelial Interface in Inflammation and Cancer , 2018, Front. Immunol..

[23]  J. Clemente,et al.  Interactions Between Diet and the Intestinal Microbiota Alter Intestinal Permeability and Colitis Severity in Mice. , 2017, Gastroenterology.

[24]  Jean-Frederic Colombel,et al.  Adherent-invasive Escherichia coli in inflammatory bowel disease , 2007, Gut.

[25]  D. Iliopoulos,et al.  Environmental triggers in IBD: a review of progress and evidence , 2018, Nature Reviews Gastroenterology & Hepatology.

[26]  A. Simmons,et al.  Microbiome, pattern recognition receptor function in health and inflammation. , 2017, Best practice & research. Clinical gastroenterology.

[27]  Mirko Trajkovski,et al.  The Immune System Bridges the Gut Microbiota with Systemic Energy Homeostasis: Focus on TLRs, Mucosal Barrier, and SCFAs , 2017, Front. Immunol..

[28]  D. Cavalieri,et al.  Diet, Environments, and Gut Microbiota. A Preliminary Investigation in Children Living in Rural and Urban Burkina Faso and Italy , 2017, Front. Microbiol..

[29]  A. Fodor,et al.  Recent urbanization in China is correlated with a Westernized microbiome encoding increased virulence and antibiotic resistance genes , 2017, Microbiome.

[30]  G. Núñez,et al.  Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease , 2017, Immunological reviews.

[31]  Xi Sun,et al.  rSj16 Protects against DSS-Induced Colitis by Inhibiting the PPAR-α Signaling Pathway , 2017, Theranostics.

[32]  M. Chamaillard,et al.  Card9 mediates susceptibility to intestinal pathogens through microbiota modulation and control of bacterial virulence , 2017, Gut.

[33]  M. Mack,et al.  Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome , 2017, The Journal of experimental medicine.

[34]  H. Kiyono,et al.  Mucosal Ecological Network of Epithelium and Immune Cells for Gut Homeostasis and Tissue Healing. , 2017, Annual review of immunology.

[35]  T. Schmidt,et al.  Neonatal acquisition of Clostridia species protects against colonization by bacterial pathogens , 2017, Science.

[36]  A. Liston,et al.  Homeostasis-altering molecular processes as mechanisms of inflammasome activation , 2017, Nature Reviews Immunology.

[37]  Helen Tremlett,et al.  The gut microbiome in human neurological disease: A review , 2017, Annals of neurology.

[38]  C. Benoist,et al.  Mining the Human Gut Microbiota for Immunomodulatory Organisms , 2017, Cell.

[39]  N. Ajami,et al.  IgA-coated E. coli enriched in Crohn’s disease spondyloarthritis promote TH17-dependent inflammation , 2017, Science Translational Medicine.

[40]  S. Plevy,et al.  The intracellular innate immune sensor NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth , 2017, Nature Immunology.

[41]  R. Sartor,et al.  Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches. , 2017, Gastroenterology.

[42]  Eran Segal,et al.  Persistent microbiome alterations modulate the rate of post-dieting weight regain , 2016, Nature.

[43]  C. Streutker,et al.  The common mouse protozoa Tritrichomonas muris alters mucosal T cell homeostasis and colitis susceptibility , 2016, The Journal of experimental medicine.

[44]  P. Wilmes,et al.  A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility , 2016, Cell.

[45]  K. Takeda,et al.  Maintenance of gut homeostasis by the mucosal immune system , 2016, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[46]  K. Koike,et al.  Targeting the complex interactions between microbiota, host epithelial and immune cells in inflammatory bowel disease. , 2016, Pharmacological research.

[47]  L. Vitetta,et al.  Modulating the Gut Micro-Environment in the Treatment of Intestinal Parasites , 2016, Journal of clinical medicine.

[48]  E. Amir,et al.  Host-Protozoan Interactions Protect from Mucosal Infections through Activation of the Inflammasome , 2016, Cell.

[49]  Gunnar C. Hansson,et al.  Immunological aspects of intestinal mucus and mucins , 2016, Nature Reviews Immunology.

[50]  A. Loukas,et al.  Helminths and Intestinal Flora Team Up to Improve Gut Health. , 2016, Trends in parasitology.

[51]  D. Underhill,et al.  Immunological Consequences of Intestinal Fungal Dysbiosis. , 2016, Cell host & microbe.

[52]  R. Xavier,et al.  Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease , 2016, Science.

[53]  Martin J. Blaser,et al.  Helminth infection promotes colonization resistance via type 2 immunity , 2016, Science.

[54]  Stephanie M. Karst.  Viral Safeguard: The Enteric Virome Protects against Gut Inflammation. , 2016, Immunity.

[55]  P. Keeling,et al.  Microsporidia - Emergent Pathogens in the Global Food Chain. , 2016, Trends in parasitology.

[56]  U. Sauer,et al.  The maternal microbiota drives early postnatal innate immune development , 2016, Science.

[57]  W. Garrett,et al.  Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut , 2016, Science.

[58]  Ajay S. Gulati,et al.  Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation. , 2016, Immunity.

[59]  R. van der Meer,et al.  Sulfide as a Mucus Barrier-Breaker in Inflammatory Bowel Disease? , 2016, Trends in molecular medicine.

[60]  Sean-Paul Nuccio,et al.  Mucosal immunity to pathogenic intestinal bacteria , 2016, Nature Reviews Immunology.

[61]  Daniel J. Wilson,et al.  Within-host evolution of bacterial pathogens , 2016, Nature Reviews Microbiology.

[62]  F. Reimann,et al.  Enteroendocrine Cells: Chemosensors in the Intestinal Epithelium. , 2016, Annual review of physiology.

[63]  Hugues Aschard,et al.  Fungal microbiota dysbiosis in IBD , 2016, Gut.

[64]  Julie K. Pfeiffer,et al.  Transkingdom control of viral infection and immunity in the mammalian intestine , 2016, Science.

[65]  Jessica K. Lang,et al.  Intestinal Epithelial Toll-Like Receptor 4 Signaling Affects Epithelial Function and Colonic Microbiota and Promotes a Risk for Transmissible Colitis , 2016, Infection and Immunity.

[66]  L. Smeeth,et al.  Obesity risk in rural, urban and rural-to-urban migrants: prospective results of the PERU MIGRANT study , 2015, International Journal of Obesity.

[67]  S. Mazmanian,et al.  Gut biogeography of the bacterial microbiota , 2015, Nature Reviews Microbiology.

[68]  Y. Cong,et al.  Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases , 2016, Journal of Gastroenterology.

[69]  Sara Omenetti,et al.  The Treg/Th17 Axis: A Dynamic Balance Regulated by the Gut Microbiome , 2015, Front. Immunol..

[70]  C. Mu,et al.  Crosstalk Between The Immune Receptors and Gut Microbiota. , 2015, Current protein & peptide science.

[71]  J. Lukeš,et al.  Are Human Intestinal Eukaryotes Beneficial or Commensals? , 2015, PLoS pathogens.

[72]  M. Sun,et al.  Regulatory immune cells in regulation of intestinal inflammatory response to microbiota , 2015, Mucosal Immunology.

[73]  D. Haller,et al.  Surface-Associated Lipoproteins Link Enterococcus faecalis Virulence to Colitogenic Activity in IL-10-Deficient Mice Independent of Their Expression Levels , 2015, PLoS pathogens.

[74]  Graham M Lord,et al.  The unusual suspects—innate lymphoid cells as novel therapeutic targets in IBD , 2015, Nature Reviews Gastroenterology &Hepatology.

[75]  D. Philpott,et al.  NOD-Like Receptors: Guardians of Intestinal Mucosal Barriers. , 2015, Physiology.

[76]  N. Caroff,et al.  Subversion of human intestinal mucosa innate immunity by a Crohn’s disease-associated E. coli , 2014, Mucosal Immunology.

[77]  F. Shanahan,et al.  The microbiota in inflammatory bowel disease , 2015, Journal of Gastroenterology.

[78]  G. Liguori,et al.  Gut Fungal Microbiota: The Yin and Yang of Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.

[79]  Bernard M. Corfe,et al.  Dysbiosis of the gut microbiota in disease , 2015, Microbial ecology in health and disease.

[80]  Jenny Sauk,et al.  Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease , 2015, Cell.

[81]  Xuetao Cao,et al.  Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease , 2015, Nature Reviews Immunology.

[82]  K. Cadwell,et al.  An enteric virus can replace the beneficial function of commensal bacteria , 2014, Nature.

[83]  J. Zhong,et al.  NLRP3 gene is associated with ulcerative colitis (UC), but not Crohn’s disease (CD), in Chinese Han population , 2014, Inflammation Research.

[84]  Harry J. Flint,et al.  The gut microbiota, bacterial metabolites and colorectal cancer , 2014, Nature Reviews Microbiology.

[85]  F. Cominelli,et al.  The Dual Role of Nod-Like Receptors in Mucosal Innate Immunity and Chronic Intestinal Inflammation , 2014, Front. Immunol..

[86]  Peer Bork,et al.  Classification and quantification of bacteriophage taxa in human gut metagenomes , 2014, The ISME Journal.

[87]  C. Huttenhower,et al.  Inflammatory bowel disease as a model for translating the microbiome. , 2014, Immunity.

[88]  William A. Walters,et al.  Communities of microbial eukaryotes in the mammalian gut within the context of environmental eukaryotic diversity , 2014, Front. Microbiol..

[89]  D. Underhill,et al.  The mycobiota: interactions between commensal fungi and the host immune system , 2014, Nature Reviews Immunology.

[90]  H. Le Moual,et al.  Host Defense Peptide Resistance Contributes to Colonization and Maximal Intestinal Pathology by Crohn's Disease-Associated Adherent-Invasive Escherichia coli , 2014, Infection and Immunity.

[91]  K. Takeda,et al.  Polysaccharide A of Bacteroides fragilis: actions on dendritic cells and T cells. , 2014, Molecular cell.

[92]  Herbert W Virgin,et al.  The Virome in Mammalian Physiology and Disease , 2014, Cell.

[93]  D. Wedekind,et al.  Norovirus Triggered Microbiota-driven Mucosal Inflammation in Interleukin 10-deficient Mice , 2014, Inflammatory bowel diseases.

[94]  W. D. de Vos,et al.  Impact of diet on human intestinal microbiota and health. , 2014, Annual review of food science and technology.

[95]  A. Keshavarzian,et al.  Regulation of Intestinal Immune Responses through TLR Activation: Implications for Pro- and Prebiotics , 2014, Front. Immunol..

[96]  F. Bäckhed,et al.  Altered Mucus Glycosylation in Core 1 O-Glycan-Deficient Mice Affects Microbiota Composition and Intestinal Architecture , 2014, PloS one.

[97]  G. Corazza,et al.  Innate and adaptive immunity in inflammatory bowel disease. , 2014, Autoimmunity reviews.

[98]  N. Barker.  Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration , 2013, Nature Reviews Molecular Cell Biology.

[99]  S. Burden,et al.  Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy. , 2013, The Cochrane database of systematic reviews.

[100]  Bing Xia,et al.  Increased Proportions of Bifidobacterium and the Lactobacillus Group and Loss of Butyrate-Producing Bacteria in Inflammatory Bowel Disease , 2013, Journal of Clinical Microbiology.

[101]  A. Kaser,et al.  Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation , 2013, Gut.

[102]  A. Dzutsev,et al.  Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis. , 2013, Cell host & microbe.

[103]  Anders F. Andersson,et al.  Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by Caesarean section , 2013, Gut.

[104]  W. Petri,et al.  Host Immune Response to Intestinal Amebiasis , 2013, PLoS pathogens.

[105]  Omry Koren,et al.  AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition , 2013, Gut.

[106]  Inacio Mandomando,et al.  Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study , 2013, The Lancet.

[107]  Frederic D Bushman,et al.  Rapid evolution of the human gut virome , 2013, Proceedings of the National Academy of Sciences.

[108]  S. Mazmanian,et al.  Innate immune recognition of the microbiota promotes host-microbial symbiosis , 2013, Nature Immunology.

[109]  P. Salamon,et al.  Bacteriophage adhering to mucus provide a non–host-derived immunity , 2013, Proceedings of the National Academy of Sciences.

[110]  I. Ivanov,et al.  Intestinal epithelial cells as mediators of the commensal–host immune crosstalk , 2013, Immunology and cell biology.

[111]  A. Gewirtz,et al.  Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis , 2013, Gut.

[112]  V. Tremaroli,et al.  The gut microbiota and mucosal homeostasis , 2013, Gut microbes.

[113]  P. van Baarlen,et al.  Host-recognition of pathogens and commensals in the mammalian intestine. , 2013, Current topics in microbiology and immunology.

[114]  J. Colombel,et al.  Secukinumab failure in Crohn's disease: the yeast connection? , 2012, Gut.

[115]  Francisco Guarner,et al.  The gut microbiota in IBD , 2012, Nature Reviews Gastroenterology &Hepatology.

[116]  R. Franiczek,et al.  Invasive properties, adhesion patterns and phylogroup profiles among Escherichia coli strains isolated from children with inflammatory bowel disease. , 2012, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[117]  D. Philpott,et al.  Nod-like receptors in the control of intestinal inflammation. , 2012, Current opinion in immunology.

[118]  N. Toft,et al.  Occurrence of Mycobacterium avium subsp. paratuberculosis in milk at dairy cattle farms: a systematic review and meta-analysis. , 2012, Veterinary microbiology.

[119]  K. Kataoka,et al.  Reduced Diversity and Imbalance of Fecal Microbiota in Patients with Ulcerative Colitis , 2012, Digestive Diseases and Sciences.

[120]  G. Núñez,et al.  Sensing and reacting to microbes through the inflammasomes , 2012, Nature Immunology.

[121]  K. Honda,et al.  The microbiome in infectious disease and inflammation. , 2012, Annual review of immunology.

[122]  G. Núñez,et al.  NLRC4-driven interleukin-1β production discriminates between pathogenic and commensal bacteria and promotes host intestinal defense , 2012, Nature Immunology.

[123]  Subrata Ghosh,et al.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.

[124]  E. Feuille.  The Antibacterial Lectin RegIII-Gamma Promotes the Spatial Segregation of Microbiota and Host in the Intestine , 2012 .

[125]  R. Ley,et al.  The Antibacterial Lectin RegIIIγ Promotes the Spatial Segregation of Microbiota and Host in the Intestine , 2011, Science.

[126]  F. Bushman,et al.  The human gut virome: inter-individual variation and dynamic response to diet. , 2011, Genome research.

[127]  R. Vance,et al.  Innate immune recognition of bacterial ligands by NAIPs dictates inflammasome specificity , 2011, Nature.

[128]  Ateequr Rehman,et al.  Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. , 2011, Gastroenterology.

[129]  G. Nava,et al.  Host genetic susceptibility, dysbiosis, and viral triggers in inflammatory bowel disease , 2011, Current opinion in gastroenterology.

[130]  Richard A. Flavell,et al.  NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis , 2011, Cell.

[131]  T. Chatila,et al.  The Toll-Like Receptor 2 Pathway Establishes Colonization by a Commensal of the Human Microbiota , 2011, Science.

[132]  R. Knight,et al.  Microbial Eukaryotes in the Human Microbiome: Ecology, Evolution, and Future Directions , 2011, Front. Microbio..

[133]  M. Chamaillard,et al.  Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury , 2011, Proceedings of the National Academy of Sciences.

[134]  Clara Abraham,et al.  Interactions between the host innate immune system and microbes in inflammatory bowel disease. , 2011, Gastroenterology.

[135]  Anders Folkesson,et al.  Evolutionary dynamics of bacteria in a human host environment , 2011, Proceedings of the National Academy of Sciences.

[136]  Hans Clevers,et al.  Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium , 2011, The Journal of cell biology.

[137]  K. Honda,et al.  Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.

[138]  N. Pace,et al.  Disease phenotype and genotype are associated with shifts in intestinal‐associated microbiota in inflammatory bowel diseases , 2011, Inflammatory bowel diseases.

[139]  T. Macdonald,et al.  IL‐23/IL‐17 axis in IBD , 2010, Inflammatory bowel diseases.

[140]  T. Kanneganti.  Central roles of NLRs and inflammasomes in viral infection , 2010, Nature Reviews Immunology.

[141]  S. Massart,et al.  Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa , 2010, Proceedings of the National Academy of Sciences.

[142]  R. Xavier,et al.  Virus-Plus-Susceptibility Gene Interaction Determines Crohn's Disease Gene Atg16L1 Phenotypes in Intestine , 2010, Cell.

[143]  Forest Rohwer,et al.  Viruses in the fecal microbiota of monozygotic twins and their mothers , 2010, Nature.

[144]  H. Herfarth,et al.  The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer , 2010, The Journal of experimental medicine.

[145]  J. Tschopp,et al.  Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome , 2010, Gut.

[146]  M. Kastan,et al.  The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. , 2010, Immunity.

[147]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[148]  Richard Bonneau,et al.  Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome , 2010, Proceedings of the National Academy of Sciences.

[149]  J. Tschopp,et al.  The Inflammasomes , 2010, Cell.

[150]  P. Donnelly,et al.  Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region , 2010 .

[151]  R. Maizels,et al.  Helminth immunoregulation: The role of parasite secreted proteins in modulating host immunity , 2009, Molecular and biochemical parasitology.

[152]  P. Sansonetti,et al.  Life on the inside: the intracellular lifestyle of cytosolic bacteria , 2009, Nature Reviews Microbiology.

[153]  J. Satsangi,et al.  Anti-Saccharomyces cerevisiae Antibodies Status Is Associated with Oral Involvement and Disease Severity in Crohn Disease , 2009, Journal of pediatric gastroenterology and nutrition.

[154]  D. Elliott,et al.  Helminths and the IBD hygiene hypothesis , 2009, Inflammatory bowel diseases.

[155]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[156]  R. Medzhitov,et al.  Innate immune recognition of the indigenous microbial flora , 2008, Mucosal Immunology.

[157]  N. Pace,et al.  Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. , 2008, Cell host & microbe.

[158]  C. Bernstein,et al.  Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases , 2008, Gut.

[159]  S. Mordon,et al.  Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3. , 2008, The Journal of infectious diseases.

[160]  K. McCoy,et al.  The immune geography of IgA induction and function , 2008, Mucosal Immunology.

[161]  D. Poulain,et al.  Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis. , 2007, Medical mycology.

[162]  M. Egger,et al.  Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. , 2007, The Lancet. Infectious diseases.

[163]  A. Shelling,et al.  Genes, diet and inflammatory bowel disease. , 2007, Mutation research.

[164]  U. Göbel,et al.  Shift Towards Pro-inflammatory Intestinal Bacteria Aggravates Acute Murine Colitis via Toll-like Receptors 2 and 4 , 2007, PloS one.

[165]  G Gerken,et al.  Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. , 2007, Gastroenterology.

[166]  E. Telemo,et al.  Impaired regulatory T cell function in germ‐free mice , 2006, European journal of immunology.

[167]  L. Hooper,et al.  Symbiotic Bacteria Direct Expression of an Intestinal Bactericidal Lectin , 2006, Science.

[168]  J. Meijerink,et al.  Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. , 2006, Gastroenterology.

[169]  J. Bertin,et al.  Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in salmonella-infected macrophages , 2006, Nature Immunology.

[170]  S. Akira,et al.  TLR1- and TLR6-independent Recognition of Bacterial Lipopeptides* , 2006, Journal of Biological Chemistry.

[171]  C. Manichanh,et al.  Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.

[172]  N. Beeching,et al.  Gastrointestinal parasites in the immunocompromised , 2005, Current opinion in infectious diseases.

[173]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[174]  R. Chiodini,et al.  Possible role of mycobacteria in inflammatory bowel disease , 1984, Digestive Diseases and Sciences.

[175]  M. Schaller,et al.  Toll-like receptors as key mediators in innate antifungal immunity. , 2004, Medical mycology.

[176]  D. Podolsky,et al.  Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. , 2004, Gastroenterology.

[177]  J. Boudeau,et al.  Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent–invasive E. coli strains isolated from patients with Crohn's disease , 2003, Alimentary pharmacology & therapeutics.

[178]  J. Bertin,et al.  Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan , 2003, Science.

[179]  M. Chamaillard,et al.  Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.

[180]  H. Buhr,et al.  Mucosal and Invading Bacteria in Patients with Inflammatory Bowel Disease Compared with Controls , 2002, Scandinavian journal of gastroenterology.

[181]  L. Holm,et al.  The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[182]  S. Yamaoka,et al.  Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB* , 2001, The Journal of Biological Chemistry.